Skip to main content
. 2014 Sep 2;53(9):787–800. doi: 10.1007/s40262-014-0165-y

Fig. 7.

Fig. 7

Day-to-day variability in glucose-lowering effect of insulin degludec (IDeg) and insulin glargine (IGlar) dosed at 0.4 U/kg over 24 h at steady state (reproduced from Heise et al. [22], with permission from John Wiley and Sons, Inc.). AUC GIR area under the glucose infusion rate profile, CV coefficient of variation